ActivePure Medical Guardian testing for FDA Class II Clearance

Testing done on the ActivePure Medical Guardian at Aerosol Research and Engineering Laboratories, a 3rd-party unaffiliated laboratory with no connection to ActivePure or its affiliates. RNA Virus: MS2 Bacteriophage. DNA Virus: Phi-X174 Bacteriophage. Gram-positive Bacteria: Staphylococcus epidermidis. Gram-negative Bacteria: Erwinia herbicola. Fungal Mold: Aspergillus niger. Bacterial Mold: Bacillus globigii.

New Study Shows ActivePure Technology’s Value as a Tool for Improving Indoor Air Quality and Infection Control

The Study

A new brief report published in the American Journal of Infection Control (AJIC) illustrates ActivePure’s Advanced Photohydrolysis (AP) Technology effectively and rapidly inactivates aerosolized SARS-CoV-2, respiratory syncytial virus (RSV), and monkeypox virus (MPXV).

The study was designed and conducted by researchers at the University of Texas Medical Branch (UTMB) to measure the efficacy of ActivePure Technology against aerosolized viral suspensions of SARS-CoV-2, RSV, and MPXV. Two devices were used: an experimental device equipped with ActivePure Technology and a control device without the technology. Measurements of the viral concentrations were taken before and after the devices were activated to determine the viral reduction achieved by the AP technology.

Key Findings

SARS-CoV-2 (the virus that causes COVID-19): ActivePure Technology significantly reduced SARS-CoV-2 concentrations by >99.83% within one minute

RSV: ActivePure Technology significantly reduced RSV concentrations by >99.98% within one minute

MPXV: ActivePure Technology significantly reduced MPXV concentrations by >99.63% within five minutes

Key Takeaways

As summarized by Dr. Deborah Birx, ActivePure’s chief medical advisor, “These results underscore the effectiveness of ActivePure Technology as a powerful tool for mitigating the spread of airborne pathogens and support other findings to date that have demonstrated the effectiveness of ActivePure Technology in clinical settings. The technology’s ability to rapidly and continuously inactivate viruses like SARS-CoV-2, RSV, and MPXV can significantly enhance infection control measures, especially in environments where vulnerable populations are at risk.”

By continuously recreating the active process of photolysis, AP technology effectively inactivates pathogens in the air and on surfaces, a fundamental distinction compared to other passive technologies or filters. Together, these factors make ActivePure Technology a vital  tool to help ensure safer indoor environments, especially in high-risk settings like healthcare facilities, schools, and long-term care settings.